ROR1 and breast cancer: Our findings lend credence to this new observation by demonstrating that lncRNA DLEU2 knockdown attenuated ROR1 expression in BC cells, restraining BC cells’ ability to proliferate, invade, migrate, and sensitize to chemotherapeutic agents.